STNE insider plans sale of 41,057 shares; prior sale of 80,440 shares
Rhea-AI Filing Summary
Form 144 notice for StoneCo Ltd. (STNE) shows a proposed sale of 41,057 common shares valued at approximately $682,970.88 to be executed on 08/28/2025 through Morgan Stanley Smith Barney on NASDAQ. The shares were originally acquired through restricted stock vesting as compensation on 01/28/2015 (14,243 shares), 04/15/2016 (8,966 shares) and 12/05/2016 (17,848 shares), totaling the shares offered. The filing also discloses a prior sale by the same person on 08/14/2025 of 80,440 shares for gross proceeds of $1,231,055.80. The filer certifies no undisclosed material adverse information.
Positive
- None.
Negative
- Planned insider sale of 41,057 shares valued at $682,970.88 on 08/28/2025
- Recent sale on 08/14/2025 of 80,440 shares for $1,231,055.80, indicating ongoing liquidation activity
Insights
TL;DR: Insider plans to sell 41,057 shares (~$683k) shortly after a recent sale of 80,440 shares (~$1.23M); transactions are from vested restricted stock.
The filing documents an insider sale under Rule 144 consisting entirely of shares originally received as compensation via restricted stock vesting in 2015 and 2016. The planned sale amount is modest relative to large-cap company float but is material at the individual level. The sale is scheduled through a broker on NASDAQ and follows a recent sale on 08/14/2025, suggesting continued liquidation of vested holdings rather than open-market purchases. No additional context (e.g., trading plan dates) is provided in the notice.
TL;DR: Transactions are routine disposition of vested shares; the filer affirms no undisclosed material information.
The record shows acquisitions via registered-plan restricted stock vesting and subsequent disposition under Rule 144. From a governance perspective, these are standard compliance disclosures confirming the seller does not possess undisclosed material information. The filing lacks any indication of a 10b5-1 trading plan or specific insider intent beyond the sales themselves, limiting assertions about timing or strategic rationale.